ANI Ready For Full-Scale Commercial Launch Of FDA-Approved Cortrophin Gel
Company’s Acquisition Of Novitium To Close This Month
ANI Pharmaceuticals has announced receiving the long-awaited FDA approval for its Cortrophin Gel and has plans for a full-scale commercial launch of the product in the first quarter of 2022. Meanwhile, ANI’s $210m acquisition of niche generics specialist Novitium Pharma is expected to close imminently.
